Clinical Trial: Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378280) titled 'Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD' on Oct. 20, 2024.

Brief Summary: A study for evaluating the safety and efficacy of L. lactis CKDB001 on liver aminotransferases in subjects with nonalcoholic fatty liver disease

Study Start Date: Aug. 18, 2021

Study Type: INTERVENTIONAL

Condition: Non Alcoholic Fatty Liver Disease

Intervention: DIETARY_SUPPLEMENT: Probiotics (L. lactis CKDB001)

L. lactis CKDB001: Enteric coated capsule with L. lactis CKDB001, daily, 12 weeks

DIETARY_SUPPLEMENT: Placebo

Placebo: Enteric coated capsule without any probiotics,...